Home/Pipeline/COVID‑19 Recombinant Protein Vaccine

COVID‑19 Recombinant Protein Vaccine

COVID‑19 prophylaxis

Phase 3Active

Key Facts

Indication

COVID‑19 prophylaxis

Phase

Phase 3

Status

Active

Company

About EVA Pharma

Egypt’s top pharma firm, EVA Pharma, combines large‑scale manufacturing with R&D to deliver diverse medicines across Africa.

View full company profile

Therapeutic Areas

Oncology Neuroscience Respiratory Cardiometabolic Medicine Anti‑infectives Ophthalmology Bone Health Pain Management Hepatology Slimming and Well‑being Sexual and Reproductive Health